$P110: Outcome of high-dose chemotherapy (HDCT) and autologous stem cell transplant (ASCT) as first salvage treatment for relapsed or refractory classical Hodgkin Lymphoma (cHL) in the era of PET-adapted strategy among Italian centers$

P110: Outcome of high-dose chemotherapy (HDCT) and autologous stem cell transplant (ASCT) as first salvage treatment for relapsed or refractory classical Hodgkin Lymphoma (cHL) in the era of PET-adapted strategy among Italian centers

Bibliographic Details
Main Authors:	Simonetta Viviani, Anna Vanazzi, Samuele Frassoni, Chiara Rusconi, Andrea Rossi, Alessandra Romano, Caterina Patti, Corrado Schiavotto, Roberto Sorasio, Vincenzo Marasco, Laura Lissandrini, Davide Rapezzi, Daniela Gottardi, Federica Cocito, Antonino Mulè, Guido Gini, Roberta Zanotti, Alessandro Rambaldi, Vincenzo Bagnardi, Corrado Tarella
Format:	Article
Language:	English
Published:	Wiley 2022-10-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000891008.01210.7b

Similar Items

P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim-PET (PET-2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patient data of three multicenter trials
by: Simonetta Viviani, et al.
Published: (2022-10-01)

Functional and Kinetic Comparison of Alanine Cysteine Serine Transporters ASCT1 and ASCT2
by: Jiali Wang, et al.
Published: (2022-01-01)

Impact of Tumour Epstein–Barr Virus Status on Clinical Outcome in Patients with Classical Hodgkin Lymphoma (cHL): A Review of the Literature and Analysis of a Clinical Trial Cohort of Children with cHL
by: Mahdi Nohtani, et al.
Published: (2022-09-01)

An overview of cancer/testis antigens expression in classical Hodgkin's lymphoma (cHL) identifies MAGE-A family and MAGE-C1 as the most frequently expressed antigens in a set of Brazilian cHL patients
by: Bortoluzzo Adriana B, et al.
Published: (2011-09-01)

Exploring the landscape of CHL strings on T d
by: Anamaría Font, et al.
Published: (2021-08-01)

Characteristics of the most recent developments in statistical methodolog
by: Corrado Gini
Published: (2013-05-01)

Rereading Bernoulli
by: Corrado Gini
Published: (2015-06-01)

The Inductive Applications of Probability Calculus
by: Corrado Gini
Published: (2015-06-01)

On the logical bases and gnosiological importance of the statistical method
by: Corrado Gini
Published: (2015-06-01)

Considerations on a posteriori probability
by: Corrado Gini
Published: (2015-06-01)

ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine‐addicted OSCC cells
by: Yijun Luo, et al.
Published: (2020-05-01)

Research Progress of Glutamine Transporter ASCT2 in Cancer
by: WANG Yale, et al.
Published: (2019-03-01)

P052: Targeting CSN5/JAB1 oncogene in classical Hodgkin Lymphoma (cHL)
by: Ioanna Xagoraris, et al.
Published: (2022-10-01)

Positivity of discrete information for CHL black holes
by: Suresh Govindarajan, et al.
Published: (2023-02-01)

Rate of primary refractory disease in B and T-cell non-Hodgkin's lymphoma: correlation with long-term survival.
by: Corrado Tarella, et al.
Published: (2014-01-01)

GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma.
by: Hong-Wei Sun, et al.
Published: (2016-01-01)

P115 (0048) BRENTUXIMAB VEDOTIN (BV) AS MAINTENANCE OR SALVAGE THERAPY AFTER ASCT FOR RELAPSED/REFRACTORY (R/R) HL
Published: (2018-10-01)

The European Institute of Oncology Thyroid Imaging Reporting and Data System for Classification of Thyroid Nodules: A Prospective Study
by: Elvio De Fiori, et al.
Published: (2022-06-01)

Progress and prospect of ASCT combined with CAR-T therapy in the treatment of multiple myeloma
by: Shihui Yuan, et al.
Published: (2024-03-01)

Autologous stem cell transplant (ASCT) for AIDS-related lymphoma (ARL)
by: Forman SJ, et al.
Published: (2009-06-01)

Homology Modeling Informs Ligand Discovery for the Glutamine Transporter ASCT2
by: Rachel-Ann A. Garibsingh, et al.
Published: (2018-07-01)

The issue of refractory disease in follicular and other lymphoma subtypes A refratariedade no linfoma folicular e em outros linfomas
by: Marco Ruella, et al.
Published: (2009-08-01)

Fortnightly variability of Chl <i>a</i> in the Indonesian seas
by: E. D. Zaron, et al.
Published: (2023-01-01)

Four-derivative couplings and BPS dyons in heterotic CHL orbifolds
by: Guillaume Bossard, Charles Cosnier-Horeau, Boris Pioline
Published: (2017-07-01)

P051: Serum procalcitonin levels in newly diagnosed classical Hodgkin Lymphoma (cHL): Correlation with other inflammatory biomarkers
by: Alexia Piperidou, et al.
Published: (2022-10-01)

P066 (0154) eBEACOPP FOR FRONT-LINE TREATMENT OF PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA (cHL) IN THE REAL WORLD SETTING
Published: (2018-10-01)

The Role of Brentuximab Vedotin (BV) as Second-Line Treatment of Refractory Classical Hodgkin Lymphoma (cHL) in the Era of Pandemic COVID-19
by: Rajabto W, et al.
Published: (2022-06-01)

BKM Lie superalgebras from counting twisted CHL dyons – II
by: Suresh Govindarajan, et al.
Published: (2019-11-01)

Disruption of Amino Acid Homeostasis by Novel ASCT2 Inhibitors Involves Multiple Targets
by: Angelika Bröer, et al.
Published: (2018-07-01)

Heterologous avian system for quantitative analysis of Syncytin-1 interaction with ASCT2 receptor
by: Kryštof Štafl, et al.
Published: (2021-06-01)

A New Methodology for Assessing the Energy Consumption of Building Stocks
by: Ilaria Ballarini, et al.
Published: (2017-07-01)

Brentuximab vedotin + AVD in cHL: cost impact on adverse events, toxicity, second malignancies, end-of-life and subsequent lines of therapy in Italy
by: Francesca Fiorentino, et al.
Published: (2023-10-01)

Co-expression of a SARP Family Activator ChlF2 and a Type II Thioesterase ChlK Led to High Production of Chlorothricin in Streptomyces antibioticus DSM 40725
by: Yue Li, et al.
Published: (2020-08-01)

D-Serine Is a Substrate for Neutral Amino Acid Transporters ASCT1/SLC1A4 and ASCT2/SLC1A5, and Is Transported by Both Subtypes in Rat Hippocampal Astrocyte Cultures.
by: Alan C Foster, et al.
Published: (2016-01-01)

The development of reading comprehension ability of Chinese Heritage Language (CHL) learners in Indonesia
by: Qinling Zhou, et al.
Published: (2024-03-01)

CHL1 and NrCAM are primarily expressed in low grade pediatric neuroblastoma
by: Wachowiak Robin, et al.
Published: (2019-12-01)

ECOSMO II(CHL): a marine biogeochemical model for the North Atlantic and the Arctic
by: V. Ç. Yumruktepe, et al.
Published: (2022-05-01)

Exact effective interactions and 1/4-BPS dyons in heterotic CHL orbifolds
by: Guillaume Bossard, Charles Cosnier-Horeau, Boris Pioline
Published: (2019-09-01)

Differential expression of CHL1 gene during development of major human cancers.
by: Vera N Senchenko, et al.
Published: (2011-03-01)

CHL1 is a selective organizer of the presynaptic machinery chaperoning the SNARE complex.
by: Aksana Andreyeva, et al.
Published: (2010-01-01)